gene knockdown

Biotech Stock News (ARWR) (GILD) (HRTX) (VRTX)

by

Arrowhead Research (NASDAQ:ARWR) On September 24, 2015 shares of Arrowhead were up as much as 20% after announcing positive phase 2a trial results for its Hepatitis B trial. Investors thought the results were good which is why the stock ended the day on the positive side. In addition to obtaining positive phase 2a Hep B … Read more

Biotech Stock News (AMPE) (ALNY) (AERI)

by

Ampio Pharmaceuticals (NASDAQ:AMPE) On April 20, 2015 Shares of Ampio Pharmaceuticals fell about 66% after the company reported that it had failed to meet the primary endpoint of a phase 3 clinical trial, known as the STRIDE trial. This trial recruited 320 patients with Osteoarthritis and patients were randomized into two different groups. One group … Read more